Literature DB >> 5774112

Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man.

J Dupre, J D Curtis, R H Unger, R W Waddell, J C Beck.   

Abstract

Intravenous administration of porcine secretin or pancreozymin or synthetic human gastrin II resulted in raised increments in serum immunoreactive insulin during intravenous infusion of glucose in normal man. Enhancement of serum immunoreactive insulin by each hormone was associated with accelerated disposal of glucose. In response to prolonged intravenous infusion of arginine with pancreozymin there was a maintained rise in immunoreactive insulin and glucagon-like immunoreactivity in the blood. These effects of pancreozymin and arginine were not reproduced with secretin and arginine, and may have been due to the stimulation of glucagon secretion together with insulin by pancreozymin. Enteric infusion of hydrochloric acid, or stimulation of gastric acid secretion by betazole, presumed to cause release of endogenous secretin, led to enhancement of insulin secretion during intravenous infusion of glucose. Enteric infusion of arginine, presumed to cause release of endogenous pancreozymin, led to a rise in serum immunoreactive insulin not attributable to effects of circulating glucose and amino acids. It is concluded that secretin and pancreozymin released in response to physiological stimuli contribute to stimulation of the endocrine pancreas after ingestion of food.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5774112      PMCID: PMC322279          DOI: 10.1172/JCI106032

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Effects of secretin on insulin and glucagon in portal and peripheral blood in man.

Authors:  J Dupré; L Rojas; J J White; R H Unger; J C Beck
Journal:  Lancet       Date:  1966-07-02       Impact factor: 79.321

2.  Effects of adrenergic and cholinergic agents upon insulin secretion in vitro.

Authors:  W Malaisse; F Malaisse-Lagae; P H Wright; J Ashmore
Journal:  Endocrinology       Date:  1967-05       Impact factor: 4.736

3.  Radioimmunoassayable glucagon levels in man: effects of starvation, hypoglycemia, and glucose administration.

Authors:  A M Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1966-02       Impact factor: 11.205

4.  Intestinal hormones and plasma insulin: an insulinotropic action of secretin.

Authors:  D R Boyns; R J Jarrett; H Keen
Journal:  Br Med J       Date:  1967-06-10

5.  Individual variation in secretory capacity of gastric acid to stimulation with solid food and with histamine.

Authors:  S J Rune
Journal:  Clin Sci       Date:  1967-06       Impact factor: 6.124

6.  Stimulation of release of insulin by an extract of intestinal mucosa.

Authors:  J Dupré; J C Beck
Journal:  Diabetes       Date:  1966-08       Impact factor: 9.461

7.  Stimulation of insulin secretion by pancreozymin.

Authors:  R C Meade; H A Kneubuhler; W J Schulte; J J Barboriak
Journal:  Diabetes       Date:  1967-03       Impact factor: 9.461

8.  Basal plasma glucagon levels of man.

Authors:  J E Sokal; E Z Ezdinli
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

9.  The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs.

Authors:  R H Unger; H Ketterer; J Dupré; A M Eisentraut
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

10.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

Authors:  M J Perley; D M Kipnis
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

View more
  42 in total

1.  The enteral insulin-stimulation after Whipple's operation.

Authors:  J F Rehfeld; F Stadil; H Baden; K Fischerman
Journal:  Diabetologia       Date:  1975-06       Impact factor: 10.122

2.  [Glucose tolerance and insulin secretion in oral and intravenous glucose load after intraabdominal operation (author's transl)].

Authors:  R Bittner; H G Beger; R Roscher; E Kraas
Journal:  Langenbecks Arch Chir       Date:  1975

3.  Gastrin and insulin release.

Authors:  J R Hayes; J Ardill; K D Buchanan
Journal:  Diabetologia       Date:  1975-02       Impact factor: 10.122

Review 4.  Secretin: Should we revisit its metabolic outcomes?

Authors:  D H St-Pierre; F Broglio
Journal:  J Endocrinol Invest       Date:  2010-05-05       Impact factor: 4.256

Review 5.  Assessment of islet function following islet and pancreas transplantation.

Authors:  Emily C Dy; David M Harlan; Kristina I Rother
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

Review 6.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

Review 7.  [Physiology and pathophysiology of the antral hormone gastrin (author's transl)].

Authors:  T U Hausamen; W P Fritsch
Journal:  Klin Wochenschr       Date:  1973-10-01

Review 8.  Hormonal control of pancreatic endocrine and exocrine secretion.

Authors:  G Youngs
Journal:  Gut       Date:  1972-02       Impact factor: 23.059

9.  Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas.

Authors:  M Otsuki; C Sakamoto; H Yuu; M Maeda; S Morita; A Ohki; N Kobayashi; K Terashi; K Okano; S Baba
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

Review 10.  Proton pump inhibitors: impact on glucose metabolism.

Authors:  Diana Boj-Carceller
Journal:  Endocrine       Date:  2012-08-12       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.